Sun Kuisheng, Mu Qingchun, Chang Haigang, Zhang Chun, Wang Yehua, Rong Shikuo, Liu Shenhai, Zuo Di, He Zhenquan, Wan Ding, Yang Hua, Wang Feng, Sun Tao
Ningxia Key Laboratory of Cerebrocranial Disease, Incubation Base of National Key Laboratory, Ningxia Medical University, Yinchuan, China.
Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, China.
Front Pharmacol. 2020 May 19;11:743. doi: 10.3389/fphar.2020.00743. eCollection 2020.
Environmental cues associated with drug abuse are powerful mediators of drug craving and relapse in substance-abuse disorders. Consequently, attenuating the strength of cue-drug memories could reduce the number of factors that cause drug craving and relapse. Interestingly, impairing cue-drug memory reconsolidation is a generally accepted strategy aimed at reducing the intensity of cues that trigger drug-seeking and drug-taking behaviors. In addition, the agranular insular cortex (AI) is an important component of the neural circuits underlying drug-related memory reconsolidation. GABA receptors (GABARs) are potential targets for the treatment of addiction, and baclofen (BLF) is the only prototypical GABA agonist available for application in clinical addiction treatment. Furthermore, ΔFosB is considered a biomarker for the evaluation of potential therapeutic interventions for addiction. Here, we used the morphine-induced conditioned place preference (CPP) paradigm to investigate whether postretrieval microinjections of BLF into the AI could affect reconsolidation of drug-reward memory, reinstatement of CPP, and the level of ΔFosB in mice. Our results showed that BLF infused into the AI immediately following morphine CPP memory retrieval, but not 6 h postretrieval or following nonretrieval, could eliminate the expression of a morphine CPP memory. This effect persisted in a morphine-priming-induced reinstatement test, suggesting that BLF in the AI was capable of preventing the reconsolidation of the morphine CPP memory. Our results also showed that the elimination of morphine CPP memory was associated with reduced morphine-associated ΔFosB expression in the longer term. Taken together, the results of our research provide evidence to support that GABARs in the AI have an important role in drug-cue memory reconsolidation and further our understanding of the role of the AI in drug-related learning and memory.
与药物滥用相关的环境线索是物质使用障碍中药物渴望和复发的有力介导因素。因此,减弱线索-药物记忆的强度可以减少导致药物渴望和复发的因素数量。有趣的是,损害线索-药物记忆的重新巩固是一种普遍接受的策略,旨在降低触发觅药和用药行为的线索强度。此外,无颗粒岛叶皮质(AI)是药物相关记忆重新巩固的神经回路的重要组成部分。GABA受体(GABARs)是成瘾治疗的潜在靶点,巴氯芬(BLF)是唯一可用于临床成瘾治疗的典型GABA激动剂。此外,ΔFosB被认为是评估成瘾潜在治疗干预措施的生物标志物。在这里,我们使用吗啡诱导的条件性位置偏爱(CPP)范式来研究在记忆提取后向AI中微量注射BLF是否会影响小鼠药物奖赏记忆的重新巩固、CPP的恢复以及ΔFosB的水平。我们的结果表明,在吗啡CPP记忆提取后立即向AI中注入BLF,但在提取后6小时或未进行提取后注入则不能消除吗啡CPP记忆的表达。这种效应在吗啡激发诱导的恢复测试中持续存在,表明AI中的BLF能够阻止吗啡CPP记忆的重新巩固。我们的结果还表明,从长期来看,吗啡CPP记忆的消除与吗啡相关的ΔFosB表达减少有关。综上所述,我们的研究结果提供了证据支持AI中的GABARs在药物线索记忆重新巩固中具有重要作用,并进一步加深了我们对AI在药物相关学习和记忆中作用的理解。